United States · FDA National Drug Code directory
CEFDINIR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-308_2c3cf3d6-130e-5a5b-e063-6394a90aeefa
- Product NDC
- 72189-308
- Form
- CAPSULE
- Composition / generic term
- CEFDINIR
- Labeler
- DirectRx
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220202
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFDINIR — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 CAPSULE in 1 BOTTLE (72189-308-14) · 72189-308-14
- 20 CAPSULE in 1 BOTTLE (72189-308-20) · 72189-308-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →